Which topic specifically covers issues arising when therapy is blinded during a trial?

Which topic specifically covers issues arising when therapy is blinded during a trial?

• A. How to Report
• B. Fatal or Life-Threatening ADRs
• C. Managing Blinded Therapy Cases
• D. Minimum Criteria for Reporting

Answer: (C)

Blinding in clinical trials aims to prevent bias, so there are specific procedures for situations where the therapy is blinded. This topic covers how to manage those cases, including when and how unblinding is allowed, who may authorize it, and how to document safety assessments without compromising the blind. It also addresses maintaining trial integrity while protecting participant safety, handling adverse events, and ensuring accurate analysis when treatment assignments are unknown. These are the issues that arise specifically because the therapy is blinded, making this the most relevant focus. General reporting or safety-reaction topics don’t address the unique management of blinded therapies.

Blinding in clinical trials aims to prevent bias, so there are specific procedures for situations where the therapy is blinded. This topic covers how to manage those cases, including when and how unblinding is allowed, who may authorize it, and how to document safety assessments without compromising the blind. It also addresses maintaining trial integrity while protecting participant safety, handling adverse events, and ensuring accurate analysis when treatment assignments are unknown. These are the issues that arise specifically because the therapy is blinded, making this the most relevant focus. General reporting or safety-reaction topics don’t address the unique management of blinded therapies.